Publication | Open Access

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

Metabolic SyndromeBiomarker (Medicine)DiabetesImmunologyDiabetes SubtypesClinical BiomarkerBiomarkersInflammatory MarkerDiabetes MellitusBiomarker DiscoveryHigh-sensitivity C-reactive ProteinMedicineAtherosclerosisEpidemiology